Five-year follow-up of patients with chronic C hepatitis and sustained virological response Seguimiento a 5 años de pacientes con hepatitis crónica C y respuesta viral sostenida
Objective: to assess persistence of sustained viral response at 5 years of follow-up in patients with chronic viral hepatitis C treated with pegylated interferon and ribavirin. Design: a descriptive study. Patients: from August 2001 to May 2004, all patients treated at our center with pegylated inte...
Main Authors: | I. Puig-del-Castillo, M. Miquel-Planas, M. Vergara-Gómez, A. Cebollero-Agustí, M. Gallach-Montero, B. Dalmau-Obrador, M. Gil-Prades, M. Casas-Rodrigo, J. Sánchez-Delgado, R. Tomás-Tutusaus, A. Gavarró-Puig |
---|---|
Format: | Article |
Language: | English |
Published: |
Aran Ediciones
2011-02-01
|
Series: | Revista Espanola de Enfermedades Digestivas |
Subjects: | |
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082011000200002 |
Similar Items
-
Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C Oscilaciones de la ferritina sérica asociadas al tratamiento antiviral en la hepatitis crónica por virus C
by: J. M. Ladero, et al.
Published: (2009-01-01) -
Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado
by: Eduardo Lorens Braga, et al.
Published: (2006-12-01) -
Side Effects of Therapy for Chronic Hepatitis C: High Incidence of Dermal and Mucosal Adverse Events
by: Hüseyin Şener BARUT, et al.
Published: (2010-03-01) -
Acute hepatitis C treatment
by: Paulo Roberto Lerias de Almeida
Published: (2010-01-01) -
Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?
by: Giovanni Faria Silva, et al.